In the cancer field, GSK-3β is commonly recognized as a putative tumor suppressor due to its well-established function as a repressor of β-catenin signaling [11] and phosphorylation-dependent down-regulation of cell-cycle regulators cyclin D1 [12], cdc25 [13], and c-Myc [14]. Here, GSK3B is linked to cancer.